NMR systems and methods for the rapid detection of analytes
This invention features systems and methods for the detection of analytes, and their use in the treatment and diagnosis of disease.
1. A method for making a Candida amplicon, said method comprising amplifying by polymerase chain reaction a Candida nucleic acid from a Candida species in the presence of a forward primer and a reverse primer to produce the Candida amplicon,
wherein the forward primer consists of the oligonucleotide sequence 5′-GGC ATG CCT GTT TGA GCG TC-3′ (SEQ ID NO:1), and the reverse primer consists of the oligonucleotide sequence 5′-GCT TAT TGA TAT GCT TAA GTT CAG CGG GT-3′ (SEQ ID NO:2).
2. The method of claim 1 , wherein the Candida species is Candida albicans , and wherein the method further comprises detecting the Candida amplicon by hybridizing the amplicon with an oligonucleotide comprising a sequence selected from the group consisting of:
5′-ACC CAG CGG TTT GAG GGA GAA AC-3′ (SEQ ID NO: 3),
and
5′-AAA GTT TGA AGA TAT ACG TGG TGG ACG TTA-3′ (SEQ ID NO:4).
3. The method of claim 1 , wherein the Candida species is Candida krusei , and wherein the method further comprises detecting the Candida amplicon by hybridizing the amplicon with an oligonucleotide comprising a sequence selected from the group consisting of:
(SEQ ID NO. 5)
5′-CGC ACG CGC AAG ATG GAA ACG-3′,
(SEQ ID NO. 6)
5′-AAG TTC AGC GGG TAT TCC TAC CT-3′,
and
(SEQ ID NO. 32)
5′-AGC TTT TTG TTG TCT CGC AAC ACT CGC-3′.
4. The method of claim 1 , wherein the Candida species is Candida glabrata , and wherein the method further comprises detecting the Candida amplicon by hybridizing the amplicon with an oligonucleotide comprising a sequence selected from the group consisting of:
(SEQ ID NO: 7)
5′-CTA CCA AAC ACA ATG TGT TTG AGA AG-3′
and
(SEQ ID NO: 8)
5′-CCT GAT TTG AGG TCA AAC TTA AAG ACG TCT G-3′.
5. The method of claim 1 , wherein the Candida species is Candida parapsilosis or Candida tropicalis , and wherein the method further comprises detecting the Candida amplicon by hybridizing the amplicon with an oligonucleotide comprising a sequence selected from the group consisting of:
(SEQ ID NO: 9)
5′-AGT CCT ACC TGA TTT GAG GTCNitIndAA-3′,
(SEQ ID NO: 10)
5′-CCG NitIndGG GTT TGA GGG AGA AAT-3′,
(SEQ ID NO: 33)
5′-AAA GTT ATG AAATAA ATT GTG GTG GCC ACT AGC-3′,
(SEQ ID NO: 34)
5′-ACC CGG GGGTTT GAG GGA GAA A-3′,
(SEQ ID NO: 35)
5′-AGT CCT ACC TGA TTT GAG GTC GAA-3′,
and
(SEQ ID NO: 36)
5′-CCG AGG GTT TGA GGG AGA AAT-3′.